Peptide detail

Argireline

Argireline (Acetyl hexapeptide-3 or Ac-EEMQRR-NH2) is a synthetic, biomimetic peptide that functions as a topical anti-wrinkle agent primarily through a neuromodulatory mechanism. Its key characteristic is its structural mimicry of the N-terminal domain of SNAP-25, a protein essential for the assembly of the SNARE complex that mediates vesicle fusion and neurotransmitter release at neuromuscular junctions. By competitively inhibiting this complex formation, Argireline reduces the release of catecholamines (e.g., acetylcholine) from synaptic vesicles, leading to a localized, reversible relaxation of facial muscle contractions. This mechanism is often described as a 'topical botox-like effect,' though it is less potent and invasive. Primary research uses focus on its application in cosmetic dermatology for diminishing the appearance of dynamic expression lines, particularly on the forehead and around the eyes. Key characteristics include its hexapeptide sequence, acetylated N-terminus and amidated C-terminus for stability, good skin penetration due to its small size and lipophilicity, and a safety profile that favors topical use over injectable neurotoxins. Research also explores its potential synergistic effects with other peptides and antioxidants in skincare formulations.